| Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation (NCT04844814) | Assistance Publique - Hôpitaux de Paris | 2022-06-02 |
| Quantify the Benefits of Biomarkers in Routine Patient Care in Kidney Transplant Recipients (NCT04774575) | Assistance Publique - Hôpitaux de Paris | 2021-12-15 |
| Urinary Biomarkers in Paediatric Kidney Transplantation (pKTx) (NCT05208788) | University Hospital Tuebingen | 2021-06-01 |
| Effects of Reflexology in Transplant Patients (NCT05833750) | Sanko University | 2020-12-01 |
| HErnias REparation After Kidney Transplantation Study (NCT04730492) | University Hospital, Montpellier | 2020-11-30 |
| Prostate Cancer in Renal Transplants Recipients (NCT04642833) | University of Florence | 2020-11-18 |
| The Safety and Efficacy of Micro-energy Ultrasound in the Treatment of Renal Insufficiency After Renal Transplantation (NCT04119427) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-05-01 |
| Intravenous Lignocaine Infusion in Laparoscopic Donor Nephrectomy (NCT04052867) | University of Malaya | 2019-09-17 |
| Comparison Thymoglobulin® and Grafalon® (NCT03996278) | University Hospital, Brest | 2019-05-22 |
| The POWERED Study: Prophylaxis With Metformin to Prevent PTDM (NCT05240274) | Barts & The London NHS Trust | 2019-01-25 |
| Envarsus XR® in Adolescent Renal Transplant Recipients (NCT03266393) | University of California, Los Angeles | 2019-01-15 |
| Impact of the Use of Remote Monitoring in the Follow-up of the Renal Transplant Patient. (NCT03750331) | Centre Hospitalier Universitaire de Saint Etienne | 2018-12-17 |
| Pneumococcal Conjugate Vaccine in Aging Renal Transplant (NCT03802994) | VA Office of Research and Development | 2018-11-01 |
| Tolerance by Engaging Antigen During Cellular Homeostasis (NCT03504241) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-07-30 |
| Endothelial Microparticules and Antibody Mediated Rejection and Kidney Transplantation: Biomarker of Antibody-mediated Rejection in Kidney Transplantation (NCT03098238) | University Hospital, Montpellier | 2017-11-30 |
| Outcome of Living Donor Renal Transplantation in Assiut Urology and Nephrology University Hospital ,Initial Experience (NCT03338140) | Assiut University | 2017-11-01 |
| Metabolomics in Assessing the Quality of Kidney Transplants Retained on a LifePort® Perfusion Machine (NCT03024229) | University Hospital, Tours | 2017-03-15 |
| Effect of Genetic Polymorphism on Calcineurin Inhibitors Levels in Egyptian Renal Transplant Patients (NCT03830255) | Helwan University | 2017-03-01 |
| Mesenchymal Stromal Cells in Living Donor Kidney Transplantation (NCT03478215) | The Methodist Hospital Research Institute | 2016-12-01 |
| Study of the Impact of VEGF Polymorphism on the Development of Renal Carcinoma in Renal Transplant Patients (NCT03114826) | Centre Hospitalier Universitaire, Amiens | 2016-10-06 |
| Combined Kidney and Hematopoietic Stem Cell Transplantation for Tolerance Induction (NCT05086003) | Rabin Medical Center | 2016-01-19 |
| A Study to Compare the Pharmacokinetics of Belatacept Using Active Pharmaceutical Ingredient Manufactured by Process E Relative to Process C (NCT02564497) | Bristol-Myers Squibb | 2015-10-02 |
| 3-month Screening Biopsy to Optimize the Immunosuppression in Renal Transplantation (NCT02444429) | Hospices Civils de Lyon | 2015-09-02 |
| Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria. (NCT02238418) | Hospices Civils de Lyon | 2014-09-01 |
| A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®) (NCT02147938) | Astellas Pharma S.A.S. | 2014-07-17 |
| Contribution of Diffusion MRI in Renal Graft Transplantation (NCT02803684) | CHU de Reims | 2014-04-01 |
| The Impact of Antimicrobial Treatment for Asymptomatic Bacteriuria in Renal Transplant Patients (NCT02113774) | Rabin Medical Center | 2014-04-01 |
| Computer Guided Doing of Tacrolimus in Renal Transplantation (NCT02010320) | University of Oslo School of Pharmacy | 2014-01-01 |
| Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM) (NCT01950819) | Novartis Pharmaceuticals | 2013-12-03 |
| Impact of Sympathetic Renal Denervation- a Study in Patients After Renal Transplantation (NCT01899456) | Technical University of Munich | 2013-07-01 |
| A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS) (NCT01822483) | Irmandade Santa Casa de Misericórdia de Porto Alegre | 2013-04-01 |
| Safety and Efficacy Study of Voclosporin and Tacrolimus in Transplantation (NCT01586845) | Aurinia Pharmaceuticals Inc. | 2013-03-01 |
| Systematic Transplantectomy Versus Conventional Care After Kidney Graft Failure (NCT01817504) | Hospices Civils de Lyon | 2013-03-01 |
| Assessing the Prevalence of Metabolic Syndrome in Renal Transplantation (NCT01753973) | University of Sao Paulo General Hospital | 2013-01-01 |
| 12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients (NCT01843348) | Novartis Pharmaceuticals | 2012-12-27 |
| Belatacept Early Steroid Withdrawal Trial (NCT01729494) | University of Cincinnati | 2012-09-01 |
| Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study) (NCT01596062) | Novartis Pharmaceuticals | 2012-03-01 |
| Hepatitis C in Renal Transplant Recipients (NCT02108301) | Prof. Dr. Alice Schmidt | 2011-12-01 |
| Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation (NCT01436305) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-09-01 |
| CE-US in Renal Transplantation (NCT01815320) | Mario Negri Institute for Pharmacological Research | 2011-04-01 |
| A Single Center, Open-label, Randomized, Pilot Study to Evaluate the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF®, Versus Tacrolimus Twice Daily, PROGRAF® in Stable Renal Recipients (NCT01742676) | Astellas Pharma Korea, Inc. | 2011-04-01 |
| Clonal Deletion on Living-Relative Donor Kidney Transplantation (NCT01408797) | Fuzhou General Hospital | 2011-03-01 |
| The Impact of Magnesium Supplementation on Insulin Resistance and Secretion in Renal Transplant Recipients (NCT01291030) | University Hospital, Ghent | 2011-01-01 |
| Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal Transplantation (NCT01276834) | Dianet Dialysis Centers | 2010-09-01 |
| Catalytic Antibodies to Predict Uninvasively Late Transplant Failure (NCT02843295) | Hospices Civils de Lyon | 2010-09-01 |
| Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation (NCT01149993) | Georgetown University | 2010-06-01 |
| Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients (NCT01068067) | Sun Yat-sen University | 2010-03-01 |
| Behavioral Contract Adherence Intervention (NCT01739803) | University of Tennessee | 2010-01-01 |
| Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients (NCT01064791) | Novartis Pharmaceuticals | 2009-12-01 |
| Association of the Intrarenal Resistance Index (RI) of Transplanted Kidneys With Generalized Atherosclerosis (NCT01001065) | University of Zurich | 2009-10-01 |
| Identification of Patients With High Probability of Poorly Responding to Therapy With Mycophenolic Acid Prodrugs (NCT00978965) | Medical University of Vienna | 2009-10-01 |
| Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program (NCT00956293) | Novartis Pharmaceuticals | 2009-07-01 |
| Initial Dosage Range of Tacrolimus by Genotyping in Chinese Renal Transplantation (NCT00935298) | The Second Artillery General Hospital | 2009-07-01 |
| A Reduced 11-b-HSD Activity, a Novel Mechanism of Salt Sensitivity and Hypertension After Renal Allograft Donation? (NCT01009229) | Insel Gruppe AG, University Hospital Bern | 2009-06-01 |
| Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids. (NCT01023815) | Novartis | 2009-04-01 |
| Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation (NCT00903188) | University Hospital, Antwerp | 2008-10-01 |
| Thymoglobulin: Presence and Affect in the Central Lymphatic Compartment (NCT00714480) | Swedish Medical Center | 2008-07-01 |
| Study Evaluating The Use Of Sirolimus In Recipients Of Kidney Allografts From Expanded Criteria Donors (ECD) (NCT00697112) | Pfizer | 2008-05-01 |
| Comparisone of Iminoral Versus Neoral in Prevention of Acute Rejection in Renal Transplantation (NCT00656695) | Imam Khomeini Hospital | 2008-04-01 |
| A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms (NCT00658333) | Novartis Pharmaceuticals | 2008-03-01 |
| Belatacept Pharmacokinetic Trial in Renal Transplantation (NCT00578448) | Bristol-Myers Squibb | 2008-03-01 |
| Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation (NCT00568477) | Technical University of Munich | 2007-12-01 |
| Interaction Between Rimonabant and Cyclosporine and Tacrolimus (NCT00525681) | University of Oslo School of Pharmacy | 2007-09-01 |
| Interstitial Lung Abnormalities in Renal Transplant Recipients (NCT01017757) | University of Parma | 2007-06-01 |
| Gene Polymorphisms in Tacrolimus Drug Interactions (NCT00620841) | KU Leuven | 2007-05-01 |
| Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic (NCT00713284) | California Pacific Medical Center Research Institute | 2007-05-01 |
| Efficacy and Safety of Enteric-coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients (NCT00413920) | Novartis | 2007-04-01 |
| The Effect of Simvastatin on Desensitization of Panel-Positive Kidney Transplant Candidates (NCT00693576) | Shiraz University of Medical Sciences | 2007-04-01 |
| Efficacy and Safety of Everolimus in Combination With Cyclosporine Microemulsion Versus Everolimus in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS), in Adult Renal Transplant Patients in Maintenance. (NCT00425308) | Novartis Pharmaceuticals | 2006-10-01 |
| Enteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) Intolerance (NCT00400400) | Novartis Pharmaceuticals | 2006-10-01 |
| Renal Transplantation With Immune Monitoring (NCT00419575) | Washington University School of Medicine | 2006-10-01 |
| Intensified vs. Standard Dose Therapy With Mycophenolate Sodium Plus Cyclosporin Microemulsion and Corticosteroid Combination in Patients With de Novo Renal Transplant Patients (NCT00369278) | Novartis Pharmaceuticals | 2006-06-01 |
| Renal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN) (NCT00337051) | University Hospital, Bordeaux | 2006-06-01 |
| A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients (NCT00369161) | Novartis | 2006-06-01 |
| Campath, Rituximab, and Myfortic With Short-Course Calcineurin Inhibitor Therapy in Renal Transplanation (NCT00579592) | University of Wisconsin, Madison | 2006-04-01 |
| Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients. (NCT00332839) | Novartis Pharmaceuticals | 2005-11-01 |
| Safety and Efficacy Study of Rituximab in Renal Transplantation (NCT00255593) | Karolinska University Hospital | 2005-11-01 |
| Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients (NCT00154297) | Novartis Pharmaceuticals | 2005-06-01 |
| Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients (NCT00154310) | Novartis | 2005-06-01 |
| Intracellular and Renal/Myocardial Tissue Concentrations of Cyclosporine A (CsA) and Rejection Frequency Following Transplantation (NCT00139009) | University of Oslo School of Pharmacy | 2005-06-01 |
| Influence of Sirolimus and MMF on Vascular Function and Markers of Cellular Function in Renal Transplant Recipients (NCT00204321) | University Hospital Muenster | 2005-06-01 |
| Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients (NCT00239876) | Novartis Pharmaceuticals | 2005-05-01 |
| Measurement of Patient Reported Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Renal Transplant Recipients (MyLife) (NCT00149968) | Novartis | 2005-04-01 |
| Protective Effect of N-acetylcysteine on Early Outcomes of Deceased Renal Transplant (NCT00994305) | University of Sao Paulo General Hospital | 2005-04-01 |
| Investigation of the Steady State Pharmacokinetics of Sirolimus, Mycophenolat Mofetil and Fluvastatin After Renal Transplantation (NCT00223028) | University Hospital Schleswig-Holstein | 2005-04-01 |
| Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes (NCT00223067) | University Hospital Schleswig-Holstein | 2005-03-01 |
| Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant (NCT00114777) | Bristol-Myers Squibb | 2005-02-01 |
| Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen (NCT00170820) | Novartis Pharmaceuticals | 2005-02-01 |
| Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients (NCT00238953) | Novartis | 2005-02-01 |
| ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients (NCT00170846) | Novartis Pharmaceuticals | 2005-02-01 |
| A Pilot Study of Campath-1H Induction Therapy Combined With CellCept® Therapy to Allow for a Calcineurin Inhibitor Free Regimen After Renal Transplantation (NCT00214266) | University of Wisconsin, Madison | 2005-01-01 |
| Study Comparing Efficacy and Safety of Mycophenolate Mofetil (Cellcept) With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Mycophenolate Mofetil and Long Term Continuation of Cyclosporine in Renal Transplant Recipients (NCT02686619) | Hoffmann-La Roche | 2004-11-01 |
| Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients (NCT00239798) | Novartis Pharmaceuticals | 2004-11-01 |
| Safety and Tolerability of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients With GI Intolerance (NCT00150020) | Novartis | 2004-10-01 |
| Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF) (NCT00154232) | Novartis Pharmaceuticals | 2004-06-01 |
| Investigation of the Steady State Pharmacokinetics of Tacrolimus, Mycophenolate Mofetil and Fluvastatin After Renal Transplantation (NCT00223015) | University Hospital Schleswig-Holstein | 2004-05-01 |
| Study of Tolerant Kidney Transplant Recipients (NCT01338779) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-05-01 |
| Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in de Novo Adult Renal Transplant Recipients (NCT00239863) | Novartis Pharmaceuticals | 2004-05-01 |
| Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients (NCT00239811) | Novartis Pharmaceuticals | 2004-04-01 |
| Correction of Anaemia and Progression of Renal Failure on Transplanted Patients (NCT00396435) | Centre Hospitalier Universitaire, Amiens | 2004-04-01 |